ETFs
D
DXR
DAXOR CORP
9.75
+0.35+3.70%After Hours: 9.40 -0.35 -3.59%17:18 06/18 EDT
OPEN/PREV CLOSE9.39/9.40
TODAY RANGE9.37-9.75
VOL3.57K
MARKET CAP56.92M
52 WEEK RANGE8.45-14.76
AVG VOL (3M)8.20K
% TURNOVER0.06%
TURNOVER--
P/E (TTM)5.38
% RANGE1.91%
EPS(TTM)1.812
P/E(FORWARD)-46.4286
P/B1.075
BVPS9.07
DIVIDEND--
P/S1,839.62
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP29.06M
SHARES OUTSTANDING5.84M
NEXT EARNINGS--
FREE FLOAT2.98M
LOT SIZE1
EX-DATE01/05/2018
News
Press Releases
Financial Reports
Profile
PUBT·06/03 20:18
Daxor announces annual shareholder meeting
TipRanks·06/02 18:06
Daxor trading resumes
TipRanks·06/02 18:00
Daxor trading halted, volatility trading pause
TipRanks·06/02 13:08
Daxor issued patent from USPTO for absolute blood volume monitoring
PUBT·06/02 12:08
Daxor wins US patent for remote blood volume monitor technology
Reuters·04/10 17:54
Daxor CEO Michael Feldschuh buys 1,000 shares for $9,070
TipRanks·04/08 12:45
Lake Street Remains a Buy on Daxor (DXR)
Reuters·03/31 22:29
Daxor CFO Robert J. Michel acquires 1,000 common shares for $9,900
TipRanks·03/17 12:25
Daxor to showcase next-gen portable BVA at ACC.26 session
Reuters·03/10 12:04
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress
Same Industry
Name/Symbol
Change%
Price